Clinical Trials Logo
  1. Home
  2. Covid19
  3. NCT05123729
  4. Details
NCT05123729 Clinical Trial

Partnerships to Address COVID-19 Inequities

COVID-19 Clinical Trial

Official title:
Community-Academic Partnerships to Address COVID-19 Inequities Within African American Communities

Clinical Trial Details — Status: Not yet recruiting

Administrative data
NCT number NCT05123729
Other study ID # IRB00099888
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date May 2024
Est. completion date September 2026

Study information
Verified date September 2023
Source Wake Forest University Health Sciences
Contact Tiarney Ritchwood, PhD
Phone 336-713-4238
Email tritchwo@wakehealth.edu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the impact of an intervention to increase COVID-19 prevention behaviors, including COVID-19 testing. The intervention will be developed through a crowdsourcing contest.

Description:

a. The surge of COVID-19 cases has been accompanied by glaring racial disparities in COVID-19-related morbidity and mortality; disparities in outcomes have been most pronounced for African Americans who, despite comprising only 13% of the US population account for about 30% of all COVID-19 cases in states for which race-related data are reported. Infectious disease modelers, epidemiologists, and other public health experts believe that COVID-19 is here to stay and suggest that annual surges may persist through 2025 and beyond. With vaccine hesitancy and delay compromising our ability to attain herd immunity, the best means for controlling the spread of COVID-19 according to public health experts is mass adoption of the 3 Ws (Wear a mask, Wait 6 feet apart, and Wash your hands) and increasing awareness of one's status through testing. As such, non-pharmaceutical interventions (NPIs) are currently our best options for viral control and containment. NPIs that are community-driven and developed in collaboration with diverse partners, including community members, public health agencies, and researchers may offer an acceptable and effective approach to reducing COVID-19 transmission and addressing individual and socio-structural barriers that lead to worse COVID-19-related outcomes among African Americans. Our study goals are to use a crowdsourcing open call to identify exceptional ideas (e.g., messages, videos, communication and dissemination strategies) that promote COVID-19 testing and encourage the public to practice the 3 Ws, referred to as health-promotive behaviors.

Recruitment information / eligibility
Status Not yet recruiting
Enrollment 200
Est. completion date September 2026
Est. primary completion date September 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - specific zip codes in North Carolina (specific zip codes to be determined) - no self-reported history of COVID-19 infection - have not tested within the past 14 days Exclusion Criteria: - live outside of study area - under 18

Study Design

Related Conditions & MeSH terms

Intervention

Behavioral:
• Crowdsourced campaign package
COVID-19 prevention intervention developed using a crowdsourcing process.
• Standard information
Standard informational videos promoting the adoption of health-protective behaviors and COVID-19 testing

Locations
Country Name City State
n/a

Sponsors (1)
Lead Sponsor Collaborator
Wake Forest University Health Sciences

Outcome
Type Measure Description Time frame Safety issue
Primary Number of participants enrolled as measured by enrollment log Number of participants enrolled as measured by enrollment log Up to 3 years
Primary Number of participants rating intervention as acceptable as measured by a post-intervention questionnaire Number of participants rating intervention as acceptable as measured by a post-intervention questionnaire Up to 4 years
Primary Change in the number of participants engaging in 1 or more of the 3 Ws as measured by participant report The 3Ws are defined as (1) Wearing a mask, (2) Waiting 6 feet apart, and (3) Washing your hands. up to 3 years; up to 38 months; up to 40 months
Primary Change in number of participants who stated that they would self-test for COVID-19 as measured by interview Change in number of participants who stated that they would self-test for COVID-19 as measured by interview up to 3 years; up to 38 months; up to 40 months
See also
  Status Clinical Trial Phase
Recruiting NCT06065033 - Exercise Interventions in Post-acute Sequelae of Covid-19 N/A
Completed NCT06267534 - Mindfulness-based Mobile Applications Program N/A
Completed NCT05047601 - A Study of a Potential Oral Treatment to Prevent COVID-19 in Adults Who Are Exposed to Household Member(s) With a Confirmed Symptomatic COVID-19 Infection Phase 2/Phase 3
Recruiting NCT04481633 - Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection N/A
Recruiting NCT05323760 - Functional Capacity in Patients Post Mild COVID-19 N/A
Completed NCT04537949 - A Trial Investigating the Safety and Effects of One BNT162 Vaccine Against COVID-19 in Healthy Adults Phase 1/Phase 2
Completed NCT04612972 - Efficacy, Safety and Immunogenicity of Inactivated SARS-CoV-2 Vaccines (Vero Cell) to Prevent COVID-19 in Healthy Adult Population In Peru Healthy Adult Population In Peru Phase 3
Recruiting NCT05494424 - Cognitive Rehabilitation in Post-COVID-19 Condition N/A
Active, not recruiting NCT06039449 - A Study to Investigate the Prevention of COVID-19 withVYD222 in Adults With Immune Compromise and in Participants Aged 12 Years or Older Who Are at Risk of Exposure to SARS-CoV-2 Phase 3
Enrolling by invitation NCT05589376 - You and Me Healthy
Completed NCT05158816 - Extracorporal Membrane Oxygenation for Critically Ill Patients With COVID-19
Recruiting NCT04341506 - Non-contact ECG Sensor System for COVID19
Completed NCT04512079 - FREEDOM COVID-19 Anticoagulation Strategy Phase 4
Completed NCT04384445 - Zofin (Organicell Flow) for Patients With COVID-19 Phase 1/Phase 2
Active, not recruiting NCT05975060 - A Study to Evaluate the Safety and Immunogenicity of an (Omicron Subvariant) COVID-19 Vaccine Booster Dose in Previously Vaccinated Participants and Unvaccinated Participants. Phase 2/Phase 3
Active, not recruiting NCT05542862 - Booster Study of SpikoGen COVID-19 Vaccine Phase 3
Terminated NCT05487040 - A Study to Measure the Amount of Study Medicine in Blood in Adult Participants With COVID-19 and Severe Kidney Disease Phase 1
Withdrawn NCT05621967 - Phonation Therapy to Improve Symptoms and Lung Physiology in Patients Referred for Pulmonary Rehabilitation N/A
Terminated NCT04498273 - COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80 Phase 3
Active, not recruiting NCT06033560 - The Effect of Non-invasive Respiratory Support on Outcome and Its Risks in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-COV-2)-Related Hypoxemic Respiratory Failure